in march 860 was the value. this stock's going higher. long-term, short-term buyer of google. >> separated out i think this goes a lot higher. >> a lot higher than here. >> i'm melissa higher. see you tomorrow for more "fast money." meantime "mad money" starts now. >> my mission is simple, to make you money. i'm here to level the playing field for all investors. there is always a bull market somewhere and i promise to help you find it. "mad money" starts now. hey i'm cramer! welcome to "mad money." welcome to cramerika. my job is to educate, teach, and coach. call me or tweet me. how the heck did this market which has been absolutely horrendous for weeks finally manage to rally with the dow

rocket 200 points? first we were oversold going into today's session. the sellers have been so willy-nilly we were down seven straight days for the dow, something we haven't seen in four years and that was back when we were in mired in political controversy. the sellers recognized they are destroying the stocks they are selling. and buyers step in. we were due for a bounce. we got it. second we got the best of both worlds from china. china became part of the cocktail hour at the beach this weekend. but it rallied up hard last night. the soft data got people to think maybe the chinese government will do more to prop up the economy. the rally in the stock market involved the government putting together some mergers. i don't think it will work in the long term. third, warren buffett made a

$37.2 billion acquisition buying precision cast parts, pcp. he tends to bust the gloom. now this deal was particularly positive because precision cast parts is largely a supplier of components for aerospace which has been in a bear market of late. he describes to the aircraft cycle confirming the views of the outgoing ceo of boeing. buffett is buying pcp at an attractive price given that the stock was higher before being laid low by the 17% of the business that was related to oil and gas. the fact that it is an industrial and the industrials have been sold endlessly should not be lost. the group jumped because of the purchase. he made bullish comments about the market and suggest head is buying more ibm. that helped the stock market

entirely. fourth, it seems that the rest of europe is siding with greece against germany and getting the aid package to the beleaguered nation. any time this deal can be closed means that europe can be mended. germany is trying to slow it down, get out of the way. fifth, the super freaking strong dollar wasn't roaring today. it got hit. wow, from the get go. maybe some of that is because greece might get a deal done. and our interest rates might not be as high as people thought. and the fed's vice chairman told bloomberg that inflation is very tame. remember the game plan, the producer price index numbers on friday are going to come out and showing deflation. it would be silly for the fed to tighten next month and that propelled the bank stocks which benefitted from the higher

rates. the tightening is on the horizon. seventh positive, oil didn't slice through the $43 level. i don't like oil here. but the fact it can bounce off a level where it held before twice might get them thinking that their bearishness is too bearish. the saudis would put out bonds rather than break the prices down to break our companies. the negativity in oil is telling but it is a smart bet. maybe today it changed. eighth we have a rotation out of the overvalued winners from the last weeks especially on the stocks that do well going into recession. i think it is giving you an opportunity to buy the recession. ninth positive, the exit for the media stocks many of which had 52 how much week lows seem to run its course.

this is the bounce that separates those with assets that are difficult to stream from the stocks with easy to stream programming. don't get complacent about this part of the rally. the investors are more enamored of internet media companies. witness the positive reaction this evening to the google reorganization where the company will become a subsidiary of a new company called alpha bit. i bet the new cf of morgan stanley suggested this because it separates the media business from all that venture capital it supports, so wall street can better understand it as a holding company that it really is, advertising, android, whatever. but media will finally shine. finally tenth, apple's rally. it has been rallying since last

week talking about slowing cell phone sales in china. that same day i was getting an opposite reading. others are getting that reading now. there is demand in china especially in the smaller cities. apple is dirt cheap. own it, don't trade it or sell it. i reiterate that in my bulletins. the vast majority of the trends have no staying power. we may go back to negative tomorrow. buffett won't be cheerleading, the oil bounce is cattish to me, dollars is the same. but it is possible for the market to rally. and that in itself tells us we can't get negative. stay skeptical, not negative, practical, not bearish. buy high-quality stocks like the ones that went down today. a recharge before they advance once again. how about greg in new york. greg? >> what's going on, jim, how you doing? >> i went to eagles training

camp. the birds look fabulous! >> caller: too bad i'm a giants fan. quick question about twitter though, where do you see the stock heading in six months to a year? >> what? where are stocks headed? i had to do a spit take there. twitter, you have a great opportunity to sell twitter into all this hoopla today. scott they got this thing done. my travel trust owns it. we're stuck in it. they got the nfl deal. i like earnings. could you give us earnings. john in illinois, please, john? >> caller: jim, this is john. i got a quick question about sprint. it's up almost 14% today coming off a 52-week low. what is your opinion of a possible cable broadcast band merger with sprint? >> i think they should do something. i was surprised the quarter was really good and that's all that

matters. what people should understand is that this group is in flux. i like verizon and at&t for the direct tv. and i have to tell you i like sprint because of that last quarter. a lot to like there. a healthy dose of skepticism doesn't hurt. don't be too negative. there are opportunities out there. like many of the stocks taking a breather today. "mad money" tonight taking a closer look at two of my favorite places to find great ideas. the new high and new low list. i'll help you mine them. and what is up with radius health? time to buy? i got co. plus my exclusive of the ceo of a bio tech that roord 26% on a huge partnership, did you miss the move on inovio? maybe not.

it took joel silverman years to become a master dog trainer. but only a few commands to master depositing checks at chase atms. technology designed for you. so you can easily master the way you bank.

all right, got to be a little contrarian here. before you are caught up in the euphoria from the relief rally, i suggest you take a breath and do some thinking because some of the move might reverse itself later this week. you know when the market goes wild to the upside i'm as critical as when we are smacked around the head on the downside. don't take your cue from the oversold action today.

right now i would rather look at my favorite two places to find ideas, the high list and low list from the end of last week. if you exclude the stocks of companies that were being acquired we had 60 new highs and 60 new lows. the new high list is more diverse than the new lows. at the moment i want to talk about the stocks in the new high list, the winners, so to speak. none of them are what you would call cheap and most took a breather today. and the stocks that made new lows managed to rally. i thought today was a counter trend day. i believe the trends will reassert themselves. the propellants are too mired in

the market. we'll dreesz the opportunities in the new low list later. i see eight groups with no high activity. the food and beverage co motor has the most participants in the high list. meanwhile this group has is most m & a activity like we saw last week. now the strength of the food and beverage names suggest that our economy is much weaker than the employment numbers indicate and if the fed tightens too aggressively we could be in a lot of trouble economically. i believe this theme has been the predominant major cord in the market. mcdonald's hormel, dr. pepper, mccormack, brown formen and costlation brands should be bought into weakness and let me throw in pepsi co too.

and my favorite player, i like wwav, white wave food. is it a natural and organic power house. they reported a terrific quarter on friday that was reminiscent of constellation brands. constellation rallied a few days later and has been roared ever since. i think that white wave will follow the same pattern. i'm a fan of general mills. as we heard there is a brilliant refresh to natural and organic coming from general mills and its main focus is domestic and it has a good yield. there are a bunch of med tech names on the high list. this group has been popular for ages. my suggestion here is a consistent company that was on last week's list, henry shine.

that is a dental supply kingpin which is four points off its high, giving you a rare buying opportunity. meanwhile, the bio tech portion of the high list, cell gene after today's run, selling 20 times its earning forewecast. these stocks are the kind of go-to higher names when the fed tightens and the economy slows down. obviously they are consistent earnings will make them the fastest growers out there. you don't use fewer product from bard or cell gene. third the home related theme is alive and well, mostly furniture but materials used to build homes. but there is only one home builder on the list. dr horton.

i would rather be in lennar. i like the higher end business. about lowe's? it's not on the list and i think it has room to run. stanley black and decker reported good numbers but not good enough. now five bucks off its high. i like that. i want to be in on that one. more people want to invest in their homes. housing prices are rising. i don't think this team will be knocked off kilter by rate hike. i don't think it could survive multiple rate hikes so this is more of a trade. fourth travel and leisure is on the list but only the bargain travel and leisure. price line, expedia, royal caribbean represent bargains as part of the frugality theme that i like so much. that is the desire to save money when you do something. but there were no hotels,

airlines or restaurants on that list except chip -- chipotle. the only department store is ross outlets. either investors don't believe that oil is going to stay down or the nonbargain names are too competitive with each other. maybe they lost their luster. none of their quarters were a blowout. the consumer is suspect until she is taking a bargain vacation. maybe we take a look at norwegian cruise lines. they filed a secondary after the close. and we are focused on the s&p 500. and fifth this is indicative of this market. information technology, what is the only part of the entire technology firment that seems to

stand out. it's the outsourcing firms of that group, back censure, equifax. they are hiding in the i.t. outsourcing stocks because they are scared of actual technology because of all the shortfalls we've seen. some of it is the strong dollar and some of it is the pull back in apple which caused a panic in what had been the strongest part of tech, cell phones. even as apple's rally since last week all portfolio managers in tech are worried about cell phones slowing. i never trust traditional tech until september. chicken tech, meaning i.t. outsourcing is a strong theme

even if you are not crazy about these companies. sixth you would think that the banks would be roaring but they aren't. and the investors fear that the fed will push up the rates too much and the banks margins will narrow. the economy could collapse. that is understandable given how an already strong dollar will go nuts to the upside after any tightening. so what is working the financials which is now the giant co motor like tech? the property, casualty and life insurers. the auto insurers business is beset by rising claims. there is more driving and texting behind the wheel. my recommend is chubb. think how narrow these groups are. the whole big groups are not

working. you know where we are seeing this strength? athletic apparel. not apparel. not retail, just athletic apparel. since nike and under armor are showing up on the high list even if the rest of apparel doesn't. consumers are willing to pay up for fitness. it's not apparel, it's fitness. that's a millennial behavior shift. it's best to wait for a pull back. this group is most extended of all these 52-week highs. and there are cat and dogs groups. the favorite is snap on, multiyear horse and autozone, they are all bias. netflix is on the list as a way of the way we consume entertainment. video games are worth buying on

any pull back. take two. we have to take a hard look at that quarter. they are in a transition phase. so here is the bottom line, the new high list is a slim group. it's not far the faint of heart. but given they are all winners if and when we get a rate hike they make plenty of sense. maybe these go down again tomorrow and you pull the trigger. stick around and we'll look at the new low list later in the show. believe it or not, i find some bargains. let's go to andrew in connecticut. >> caller: i got a question for you. >> yes. >> caller: in your book, you say if you keep a file of the raise stocks and buy them on down days you will be making a boat load of money. since bri has people at the top and bottom line, it is up only

2.72% since august 5th it is down 4.61 while the market is flat. my question is does this decline represent a down day and are you a buyer here? >> i like this call that you're making. i like the yield and the new management and the gasoline going down. i think you've got the right one. be careful, the restaurants are not on the new high list. the only one that came in is chipotle. but darden is levered to oil. the ceo told us that on this show. i like your call and think it's a smart one. the new high list is one of my favorite places to find an opportunity. when they pull back you get to pounce. this list is not for the faint of heart but has solid winners. much more mad ahead including a dive into the new low list. they look battered and bruised but not all the names are broken. then radius health lost some attitude over the last few weeks

but the stock is still up 70% for the year. and my exclusive with one of the hottest stocks of today's action, inovio. we're going under the radar to check that one out. 20% rally on a big partnership with astrazeneca. you want to find out more, believe me. stick with cramer.

we've gone through last week's new high list. what habit the new low list. it looks like a pile of rubble after a bear set up an improvised explosive device. everything looks broken and busted. this is about the horrendous decline in oil and in just commodity fatigue. but i don't expect to repeat the last. when i look at the oil stocks i have to tell you that an optimist would believe that a level can hold. but there has been so much destruction. most of the stocks are independent oil and gas companies or drillers and oil service companies that may not survive the era intact. i would use the strength of the bounce to lighten up from the new low list last week. since they are on that list for good reasons either because

their balance sheets are stretched or oil is not coming back fast enough. that's why it's so hard to find anything to buy on this list. so many industrials that have been intriguing in other eras like emerson, dover, old line manufacturing companies are so tide now to the oil cycle they have no support here. i'm particularly shocked at emerson which was among the top five industrial companies we had in this country. there is no silver lining except maybe an act activist. let's me give you seven i'm eyeing for opportunities. while no investor can time anything perfectly these stocks make sense to nibble at now. your perspective not wrong. start with alcoa. that has been a one-way ticket

to hades. it is not getting credit for the transformation. next applied materials who report this week. it has been thrown off by the tokyo electron merger. i don't think it's reflected at this these levels. third, many utilities have come down, but few as come down as much as entergy. we had them on. a power producer in the southeast. what a great place to get started even if the fed triples rates in three months i would like them with a 4.8% yield. and it is trading well below a clear identifiable book value. it's lowe's. it's not a hot oil driller but

owns 89% of cna. the book value is a scrubbed clean 51 bucks but the stock is barely over 39. it is hard to believe that the company's stake in diamonds should penalize them that greatly. the fifth opportunity is spectra energy. a pipeline play with a 5% yield that crushed the estimates last week. the company is bringing in cheap shale gas in the northeast. i can't be that negative. this is a utility! sixth i'm not going to tell you to buy exxon right now but is it the most conservative oil and gas company out there. so if its yield is at 3.8, if it climbs to 4 or 5 i buy it with my eyes shut. proctor and gamble. it's bloelted and getting its butt kicked and getting in the wrong direction but if i can get them with a 4% yield i'm going

to make a bet that the new ceo can fix the company. and you are being paid to wait. i know it's not a great reason to recognize the stock. there it is. bottom line, most of the new low list is made up of oil and gas companies but if you take a look there are worth while opportunities in the losers of the market provided you have patience, which i know these days is in very short supply. about gary in california. >> caller: good evening mr. cramer. my question is regarding johnson controls. jci. jci management recently announced it is spinning off his automotive experience division which makes car seats and auto equipment. is this move guess whering the stock price? >> it's advancing it but is it an industrial. and the industrials have fallen so far out of favor you can see

warren buffett sneak in and buy it for cheap. the group is overdone to the downside but i'm not a hero and i don't want you to be either. i went through the new low list and many are the oil and gas companies but some battered names are bargains right now. much more ahead including radius health. the stock is up 70% this year but can the pipeline support more gains? i've got the ceo. and the underrated bio tech that rose today. let's get to your calls lightning round stick with cramer!

it's a golden opportunity to elevate each moment. ♪ hit every mark. ♪ thread every needle. ♪ turn every ride into a thrill ride. ♪ come in to the lexus golden opportunity sales event, where you'll find some of the best offers of the year on our most exhilarating models. lease the 2015 rc 350 for $449 a month for 36 months and we'll make your first month's payment. see your lexus dealer.

after a day where the averages rebounded like crazy i thought we were circling back to a once red hot stock, radius health, rdus. it's a bio tech company that treat end krin mediated disordered. they got to 8 bucks three years ago and got as high as $83. down to 65 today. some of that is because the company did a 4.66 million share secondary and that gave them $325 million worth of cash meaning it can fund itself for some time. when you issue a bunch of shares it's natural for the stock to go down. and the stock plunged down the 68 because the company posted a larger than expected loss. they are in the development stage. it doesn't have products on the market. for these companies we don't

care about the quarterly results. what matters is the drugs in the pipeline. and in the case of radius they have a strong osteoporosis drug in phase three and works better than the current standard of care. that story hasn't changed one bit. nor have its treatments for breast cancer or the vasomotor is symptoms of menopause. let's check in with bob ward, the president of radius health. welcome back to "mad money." good to see you, sir. i feel like we should talk about the hot flash and breast cancer drugs because you've hired someone, dr. lorraine fitzpatrick, chief medical office. she is going to be speaking this fall. she is a big hire and it might

matter. >> lori fitzpatrick was at am general and gsk. she brings deep experience not just in osteoporosis. and at asbmr, she will be presenting the major ost osteoporotic study out of our active and active extend. and we got an oral plenary presentation. >> for the people who are not that familiar. can you explain what that means and why that is so important say if you weren't. >> at the american side of bone and mineral research is the big american based bone meeting each year and the committee reviews the presentations to see which will have the biggest impact. so our active extend trial was selected as an oral plenary

presentation. this is the marquee presentation. and we're fortunate that dr. felicia costman will be presenting that. >> your main drug was not fast tracked by the fda. you didn't seem surprised. it didn't necessarily mean a huge setback right? >> our base case has been a regular nda submission and regular approval here in the u.s. and in europe an maa for a regular review as well. in the u.s. there are four programs you can apply for. and we'll apply for each as we go through them. it's not uncommon that these are not granted. they are granted as a rare exception but it's upside if it's awarded. >> the thing that i was concerned about was -- it's clearly noticeable and better than the alternative. but when there is an alternative on the market the fda seems

reluctant to fast track the competitor. >> it depends on the clinical profile. what got us excited is on fractures, we did an analysis, the analysis showed a reduction as compared to forteo. in europe, reducing the fractures is an important part of how the programs are evaluated. we are excited about this data. >> the decline in the stock comes at a -- in a -- there is no such thing as a positive decline but you have enough money to go through how many of the trials without having to worry about having to sell out or give away rights to something. >> it put the launch on our balance sheet. we are talking with partners today. we are a development engine. we finished a phase three program and getting ready to

submit. but we want a partner to work with us to commercialize the drug around the globe. but we also have a pipeline. most bio tech don't have necessarily more than one big idea. rad 1901 in breast cancer we showed in a pre-clinical model that the two drugs used in combination with our 1901 had a more important impact on tumor growth than either drug alone. since that happened, phone has been ringing off the hook. folks want to work with us. >> my point, we had a big home run with receptos. it had enough money and it could call its own shots. it didn't have to sell out if it didn't want to. it could partner and get taken over. and it was fabulous for our viewers. radius has more than one shot on goal and has the capital. you don't have to beg. >> absolutely.

we can pick the right partner. >> that's what we want. that's bob ward. radius health president and ceo. they have many shots on goal including some that will break next year. can it make a dentist appointment when my teeth are ready? ♪ can it tell the doctor how long you have to wear this thing? ♪ can it tell the flight attendant to please not wake me this time? ♪ the answer is yes, it can. so, the question your customers are really asking is, can your business deliver? aa chance to try somethinglook. different.

this summer, challenge your preconceptions and experience a cadillac for yourself. take advantage of our summer offers. get this low mileage lease on select ats models, in stock the longest, for around 269 per month. ♪ introducing the samsung galaxy s6 active only from at&t. tested to withstand pretty much anything life throws your way. switch to at&t and get a $300 credit with eligible purchase and trade-in. 96% of them are doing rain-fed agriculture. .

they're all competing with each other; they're all making very low margins, making enough to survive, but not enough to get out of poverty. so kickstart designs low cost irrigation pumps enabling them to grow high value crops throughout the year so you can make a lot of money. it's all very well to have a whole lot of small innovations, but unless we can scale it up enough to where we are talking about millions of farmers, we're not going to solve their biggest challenge. this is precisely where the kind of finance that citi is giving us, is enabling us to scale up on a much more rapid pace. when we talk to the farmers and ask them what's the most important thing. first of all they say we can feed our families. secondly, we can send our children to school. it's really that first step that allows them to get out of poverty and most importantly have money left over to plan for the future they want.

it is time. it is time for the lightning round. and then lightning round is over. are you ready? time for the lightning round. dave in new york? >> caller: hi, jim. i've been a long time viewer of "mad money.." >> excellent. thank you. >> caller: i hold a profitable position in pipeline company epd. but over the last year the stock has fallen about 30% from its high point. i realize that it has big declines but i thought that pipeline companies were insulated from these decreases. do you advise that i sell or hold? >> this group is way overdone on the downside and that epd is the

best of the lot. that is not a strong endorsement about whether it's going to go up now. but i'm going to tell you that i like the stock. it's a premier mass limited partnership and all of those heavily underwater right now. daniel in california, daniel? >> caller: jim, booyah from the suburb of northridge. >> what's up? >> caller: my buddy and i were talking about the advancement of tech and video games and desire for entertainment. what is the thought of dave and busters? >> that is a hard business. they came public again and are doing a good job. i'm going to endorse dave and busters. i talked with their business model over the weekend. they are make it. and going to california. >> caller: average dollar value stock ticker ipcm. how to use this to time the

merger that happened a couple weeks ago? >> i don't understand that merger. i don't understand it. i have to do more work on it. you ring the register. but we have to find out more. >> jim in new york. jim? >> caller: booyah jim. buy, sell, or hold helen of troy. >> is it overdone on the downside. let's go to joe in ohio. >> caller: thanks for taking my call. >> absolutely. >> i realized a 30% gain on ndxg. i took it off the top and it dropped about 25%. >> this is a speculative stock. this is something that everyone is trying to do, regenerate material in the body. i have stocks like radius. i would rather be in radius,

rdus. down a great deal and we like the management. steve in michigan. steve? >> caller: hi, jim, my question is on mgm. >> i like mgm. i think it's the cheapest of the three. it's the one i like. and that is the conclusion of the lightning round! >> the lightning round is sponsored by dt ameritrade. let me show you. okay. our thinkorswim trading platform aggregates all the options data you need in one place that lets you visualize that information for any options series. okay, cool. hang on a second. you can even see the anticipated range of a stock expecting earnings. impressive... what's up, tim? for all the confidence you need. td ameritrade. you got this.

look at inovio up 26% on the news of a partnership with astrazeneca that could be worth up to $700 million in future milestone payments. here's a small development stage bio tech company with a proprietary immune therapy platform and cutting edge vaccine technology. they can create a fragment of dna and inject it in your cells that help your immune system fight all sorts of diseases. astrazeneca partnered to inovio to get to a therapy that generates t-cells that account for 70% of cervical cancer. the drug is phase two. and while astrazeneca has the rights to it.

inovio could get double digit royalties on top of the milestone payment. and this company's market capitalization is less than $600 million. and it's an endorsement of the technology, the thesis behind the company. the company has a broad pipeline of similar early-stage products. none are near coming to the market but it's possible it could be worthman than the $8 where it is right now. i think this is an intriguing story and more importantly, astrazeneca does and they know more than i do. let's talk to the president and ceo of inovio pharmaceuticals. welcome. good to see you. >> glad to be here. >> i know the company has been around for a while and has been working on very difficult science. i look at what astrazeneca did.

that this is an endorsement of your life's work. >> absolutely. in short it's all about the t-cells. you need the t-cells it's like the navy seals of your immune system to seek out and destroy the cancer cell and that's what inovio's drug can do. >> a bunch of companies are working on immune therapy. we try to figure out what is different? why is one better than the other. how does your differ from a lot of them who said we are immune therapy. look at us, we've got the goods? >> what makes inovio different and unique and perhaps better is our ability to generate the specific t-cells in the body. we are generating these killer t-cells, professional killers, navy seals that can seek out the cancer cells in the body specific to the cancer types better than anyone out there.

>> you are targeting not just cancers but hep-b, influenza and ebola work. >> it's the same platform, synthetic dna based technology that allows us to go after these multiple types of diseases, including cancer and infection. >> is this deal -- i know it's great milestones. sometimes i want the company that i recommend have everything and not use a partner. why is it good to use a partner right now? is this like giving things away at the finish line or just an ideal partner for you? >> we have a strong platform that we can pump out products today, tomorrow and the next day. we have a strong farm team that can pump out strong first-line players. so partners with medimmune for

ino 3112 and a couple of draft picks allows to grow and expand and build on more products in the pipeline. >> were many companies knocking on the door and you liked astrazeneca? >> absolutely. there were multiple potential suitors. we loved az and medimmune because of their aggressiveness and positioning in this competitive area. >> this has taken a long time. why now? why give away some of the upside now or you just finally have so many things going it's worth it to partner for this element? >> we're partnering on first ino 3112 for head and neck and cervical cancer but we have plenty of other products in the pipeline, prostate cancer, breast, lung, and pancreas. so we can build on the strong

partnership with medimmune, who by the way, has a very strong pipeline of check point inhib or immune therapy models that can be used in combination of our products. this is a perfect one-two punch to go after these tough to treat cancer cells. >> it's a big day for your company. that's the president and ceo of inovio pharmaceuticals. there is a lot of articles about it today. attention investors! vectorvest mobile is here and it's free! make faster, smarter, better trading decisions with ctorvest mobile. the most powerful app or managing your portfolio from the palm of your hand. only vectorvest mobile analyzes, ranks and graphs... ...over 16,000 stocks worldwide, everyday,... ...and gives you clear buy, sell, hold recommendations...

...on every stock; anytime, anywhere. vectorvest mobile comes free with your vectorvest trial. get it now! visit vectorvest.com/mobile to get started

at ally bank no branches equals great rates. it's a fact. kind of like shopping hungry equals overshopping.

never be complacent about an oversold rally. it's like an overbought selloff. when the market is up big and everything goes down, look at the rubble day one. day two, everything went up day one and now you have to think about what to sell day two, not what to buy. let's talk google. the new formation allows you to break out what is winning from what is losing. and google, android is good. search isn't part of the media company. the rest of it we can cordon it off and make sense of it. the cfo of morgan stanley knows what she is doing. i'm jim cramer. i will see you tomorrow!

lemonis: tonight on "the profit"... that was freakin' awesome. ...a baseball-novelty business based in coopersburg, pennsylvania, has struck out with their key major league baseball clients... you don't even know what you have in here. ...and the stubborn owner... it's toxic in here. ...who has a hard time letting go of the past. honestly, you can't be in this business anymore. scott: i've been doing this for 25 years. lemonis: if i can't change the focus of this all-american business... if you don't evolve, you will die. wendy: [ voice breaking ] you know, i worry about his sleepless nights, his stress. lemonis: ...then it may just be game over. scott: cowboy up. lemonis: my name is marcus lemonis, and i fix failing businesses. if you don't like money, don't follow my process. i make the tough decisions. we're closing the store. we're done.